Modena, Italy

Valeria Marigo

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Mireca Medicines Gmbh, Graybug Vision, Inc.. Active years: 2019-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Valeria Marigo. Retrieved from https://idiyas.com/inventor/valeria-marigo-vl2s03qu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Valeria Marigo: Innovator in Cyclic Nucleotide Research

Introduction

Valeria Marigo is a prominent inventor based in Modena, Italy. She has made significant contributions to the field of cyclic nucleotide research, particularly through her innovative patents. With a total of three patents to her name, Marigo's work focuses on the modulation of the cGMP-signaling system, which has important implications for various biomedical applications.

Latest Patents

Marigo's latest patents include groundbreaking inventions such as "Polymer linked multimers of guanosine-3', 5′-cyclic monophosphates." This invention is directed towards new polymer linked multimeric guanosine-3',5′-cyclic monophosphate (cGMP) analogues that modulate the cGMP-signaling system. These analogues preferably exhibit activating properties and serve as activators of cGMP dependent protein kinase (PKG). The invention also encompasses related monomeric compounds that may show modulating activity and can be used as reagents for signal transduction research.

Another notable patent is "Equatorially modified polymer linked multimers of guanosine-3', 5′-cyclic monophosphates." This invention focuses on new equatorially modified polymer linked multimers of cGMP analogues that inhibit the cGMP-signaling system. Similar to her previous patent, this invention also relates to monomeric compounds that may serve as precursors and have inhibitory activity. These compounds are valuable for research and diagnostic applications.

Career Highlights

Throughout her career, Valeria Marigo has worked with notable companies such as Mireca Medicines GmbH and Graybug Vision, Inc. Her expertise in cyclic nucleotide research has positioned her as a key figure in the development of innovative therapeutic solutions.

Collaborations

Marigo has collaborated with esteemed colleagues, including Hans-Gottfried Genieser and Andreas Rentsch. These collaborations have further enhanced her research and contributed to the advancement of her inventions.

Conclusion

Valeria Marigo's contributions to cyclic nucleotide research through her innovative patents highlight her role as a leading inventor in the field. Her work continues to influence research and applications in biomedical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…